Physician profile
Todd A Halper
NPI 1518126655
$15,124.72
in general payments reported to CMS, 2019-2025
78 companies · $1,548 in 2025
The $1,548 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,274 · 2020: $2,302 · 2021: $2,391 · 2022: $2,120 · 2023: $1,385 · 2024: $2,105 · 2025: $1,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,018 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,017.61 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,284.77 | 2020-2025 | |
| Novo Nordisk INC | $1,145.81 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $848.53 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $789.89 | 2019-2024 | |
| Lilly USA, LLC | $746.50 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $659.72 | 2019-2025 | Capvaxive, Gardasil 9, Belsomra |
| Glaxosmithkline, LLC. | $557.39 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $436.22 | 2019-2024 | Farxiga |
| Antares Pharma, INC. | $413.93 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Alkermes, INC. | $367.68 | 2019-2023 | Vivitrol |
| Gilead Sciences, INC. | $355.72 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $333.70 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $317.69 | 2019-2022 | |
| Pfizer INC. | $310.09 | 2019-2024 | |
| Bausch Health US, LLC | $267.81 | 2020-2025 | Aplenzin |
Show all 78 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $263.38 | 2019-2025 | Spravato, Xarelto |
| Amgen INC. | $252.91 | 2019-2025 | Repatha, Otezla, Repatha |
| Intra-Sana Laboratories | $250.08 | 2022-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Takeda Pharmaceuticals U.S.A., INC. | $249.12 | 2019-2023 | Gattex |
| Sanofi-Aventis U.S. LLC | $247.21 | 2019-2023 | |
| Verity Pharmaceuticals INC. | $213.25 | 2024-2025 | Tlando |
| Indivior INC. | $191.61 | 2019-2025 | Sublocade |
| Abbott Laboratories | $179.09 | 2019-2024 | Freestyle Libre 3, Aveir |
| Mdd US Operations, LLC | $173.20 | 2019-2020 | |
| Amarin Pharma, INC. | $171.64 | 2019-2021 | |
| Axsome Therapeutics, INC. | $152.10 | 2024-2025 | Auvelity |
| Erbe USA INC | $149.00 | 2024 | |
| Exact Sciences Corporation | $148.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ardelyx, INC. | $145.25 | 2024 | Ibsrela |
| Biohaven Pharmaceutical Holding Company Ltd. | $133.74 | 2022 | |
| Eisai INC. | $130.95 | 2020-2025 | |
| Ironshore Pharmaceuticals INC. | $125.15 | 2019-2022 | |
| Horizon Therapeutics Plc | $114.18 | 2019-2022 | |
| Esperion Therapeutics, INC. | $108.15 | 2020-2022 | |
| Halozyme INC | $96.74 | 2023 | |
| Shield Therapeutics INC | $92.41 | 2022-2025 | Accrufer |
| Neos Therapeutics, Lp | $89.91 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $89.89 | 2021-2025 | Rexulti |
| Hologic Sales and Service, LLC | $79.15 | 2022-2025 | Aptima |
| Renalytix Ai, INC. | $78.95 | 2023-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Tolmar, INC. | $77.25 | 2024-2025 | Jatenzo |
| Teva Pharmaceuticals USA, INC. | $72.15 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $71.86 | 2019-2021 | |
| Medicomp INC | $69.81 | 2022 | |
| Aytu Biopharma, INC. | $68.22 | 2019-2021 | |
| Orexo US, INC. | $65.00 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $60.95 | 2019 | |
| Inspire Medical Systems, INC. | $60.07 | 2024-2025 | Inspire |
| Arbor Pharmaceuticals, INC. | $59.45 | 2019-2020 | |
| Masimo Corporation | $54.36 | 2021 | |
| Supernus Pharmaceuticals, INC. | $51.33 | 2022-2023 | Xyosted, Qelbree |
| Amneal Pharmaceuticals LLC | $49.93 | 2024 | Unithroid |
| Medtronic, INC. | $47.96 | 2024 | Ligasure, Closurefast |
| Clarus Therapeutics INC. | $37.09 | 2021 | |
| Novartis Pharmaceuticals Corporation | $36.32 | 2022-2024 | |
| Linus Health, INC. | $35.26 | 2023 | |
| Endo Pharmaceuticals INC. | $34.53 | 2019 | |
| Ibsa Pharma INC. | $32.53 | 2019-2020 | |
| Uswm, LLC | $30.38 | 2021 | |
| Adlon Therapeutics L.P. | $26.76 | 2021 | |
| Corcept Therapeutics | $23.81 | 2025 | Korlym |
| Zyla Life Sciences, INC. | $23.74 | 2019 | |
| Dexcom, INC. | $23.49 | 2021 | |
| Lundbeck LLC | $21.27 | 2020 | |
| Braeburn INC. | $20.14 | 2025 | Brixadi |
| Philips North America LLC | $19.28 | 2024 | (Ck7) Extended Holter |
| Avanir Pharmaceuticals, INC. | $18.90 | 2019 | |
| Phathom Pharmaceuticals, INC. | $18.48 | 2024 | Voquezna |
| Embecta Corp. | $17.95 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Beta Bionics, INC. | $17.43 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Avanos Medical | $16.71 | 2021 | |
| Redhill Biopharma INC. | $16.05 | 2020 | |
| Idorsia Pharmaceuticals US INC | $15.33 | 2023 | Quviviq |
| Shire North American Group INC | $15.00 | 2019 | |
| Corium, LLC | $14.60 | 2023 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.59 | 2021 | |
| Evoke Pharma, INC. | $13.16 | 2024 | |
| Hikma Pharmaceuticals USA | $12.88 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Halper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.